Kronos Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Kronos Bio, Inc. reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $3.37 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2021-05-11
- Kronos Bio, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2021-03-31 was $3.37, a 921.21% increase year-over-year.
- Kronos Bio, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2020-03-31 was $0.33.
- Kronos Bio, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2020 was $1.01, a 621.43% increase from fiscal 2019.
- Kronos Bio, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2019 was $0.14, a 366.67% increase from fiscal 2018.
- Kronos Bio, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2018 was $0.03.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|
| 2021-03-31 | $3.37 10-Q · filed 2021-05-11 | ||
| 2020-12-31 | $1.01 10-K · filed 2021-03-23 | ||
| 2020-09-30 | $0.69 10-Q · filed 2020-11-18 | ||
| 2020-03-31 | $0.33 10-Q · filed 2021-05-11 | ||
| 2019-12-31 | $0.14 10-K · filed 2021-03-23 | ||
| 2019-09-30 | $0.09 10-Q · filed 2020-11-18 | ||
| 2018-12-31 | $0.03 10-K · filed 2021-03-23 |